InMode Revises Full-Year 2023 Guidance

About this update from Inmode Ltd.

[{"type":"text","content":"YOKNEAM, Israel, Dec. 6, 2023 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it is revising its full-year 2023 guidance.\n\nAccording to management, this revision is primarily due to stronger-than-expected headwinds from the current macroeconomic environment, resulting in a slowdown in platform sales, mainly in North America.\nBased on current estimates, management expects:\nRevenue for the full year 2023 to be in the range of $485 million to $495 million, as compared to the prior estimated range of $500 million to $510 million.Non-GAAP gross margin[1] for the third quarter of 2023 to remain in the range of 83% to 85%.Non-GAAP income[1] from operations to be in the range of $214 million to $218 million, as compared to the prior estimated range of $220 million to $225 million.Non-GAAP earnings[1] per diluted share for the full year 2023 to be in the range of $2.47 to $2.50, as compared to the prior estimated range of $2.53 to $2.57.1. Please refer to \"Use of Non-GAAP Financial Measures\" below for important information about non-GAAP financial measures. Non-GAAP results exclude share-based compensation.\nAbout InMode\nInMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency (\"RF\") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted, minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.\nForward-Looking Statements\nThe information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the future performance described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as \"anticipate,\" \"believe,\" \"est...

More updates from Inmode Ltd.